Fundz

Rayze Bio, Inc. reported raising $109 Million in an initial SEC Form D filing, from an offering of $109 Million

PRIVATEJun 10, 2021

Amount Raised

$109 Million

$109 Million sold, per SEC Form D (first sale Jun 10, 2021)

Round Type

Venture

San DiegoBiotechnology

Quick answer

RayzeBio, Inc. raised $109 Million in a funding round, dated June 10, 2021. RayzeBio, Inc. is based in San Diego, California, United States.

How much did RayzeBio, Inc. raise?
RayzeBio, Inc. raised $109 Million in a funding round on June 10, 2021.
What does RayzeBio, Inc. do?
RayzeBio Inc. is now part of Bristol Myers Squibb.
Where is RayzeBio, Inc. based and how big is it?
RayzeBio, Inc. is based in San Diego, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as RayzeBio, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Transcera Inc. raised $1M (Seed) on July 23, 2021.
  • Wugen raised $99M on July 23, 2021.
  • Wugen raised $37M on July 23, 2021.
  • Arzeda raised $26M on July 22, 2021.
  • Kandu Health™ raised $260M on July 22, 2021.
  • Anocca raised $47M (Series B) on July 22, 2021.

Who to call at RayzeBio, Inc., and when

A new round usually means RayzeBio, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day RayzeBio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RayzeBio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RayzeBio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RayzeBio, Inc.

Location

5505 MOREHOUSE DRIVE, SUITE 300

San Diego, California, United States

About

RayzeBio Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies through our differentiated radiopharmaceutical platform @Bristol Myers Squibb or www.bms.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RayzeBio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for RayzeBio, Inc.'s next move

See what Strategic adds

RayzeBio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.